Navigation Links
Cardiac Science Increases R&D Capacity With 3-year Syncroness Agreement
Date:2/4/2009

BOTHELL, Wash., Feb. 4 /PRNewswire-FirstCall/ -- Cardiac Science (Nasdaq: CSCX), a global leader in advanced cardiac diagnosis, resuscitation, rehabilitation, and informatics products, completed a three-year agreement for product design and engineering services from Colorado-based Syncroness, a leading design and engineering firm serving the medical devices industry.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080306/AQTH510LOGO)

"We expect considerable savings and speed-to-market improvements with Syncroness," said Bob Odell, vice president of engineering for Cardiac Science. The agreement increases Cardiac Science's engineering capacity to manage sustaining activities and new business opportunities. Odell adds, "This will allow seasoned Cardiac Science team members to focus on new customer solutions, revenue opportunities, and new advances in technology. As a result, we'll be even faster and more responsive to market needs."

"We've worked with Cardiac Science on a smaller scale and I can say they are a great partner," said chief marketing officer Jorg Lorscheider. "I'm confident we will reward Cardiac Science's trust with lowered costs, product development efficiencies, and an improved speed-to-market."

About Cardiac Science

Cardiac Science develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including automated external defibrillators (AEDs), electrocardiograph devices (ECGs), cardiac stress systems and treadmills, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, and cardiology data management systems (informatics) that connect with hospital information (HIS), electronic medical record (EMR), and other information systems. The company sells a variety of related products and consumables and provides a portfolio of training, maintenance, and support services. Cardiac Science, the successor to the cardiac businesses that established the trusted Burdick(R), HeartCentrix(R), Powerheart(R), and Quinton(R) brands, is headquartered in Bothell, Washington. With customers in more than 100 countries worldwide, the company has operations in North America, Europe, and Asia. For information, call 425.402.2000 or visit http://www.cardiacscience.com.

About Syncroness

Syncroness (Westminster, CO) is a leading product design firm and a pioneer in the development of advanced business processes for engineering that increase profit and performance for the organizations we serve. For information, call 877.429.5005 or visit http://www.syncroness.com.

Forward-Looking Statements

This press release contains forward-looking statements. The words "believe," "expect," "intend," "anticipate," variations of such words, and similar expressions identify forward-looking statements, but their absence does not mean that the statement is not forward-looking. Forward-looking statements in this press release include, but are not limited to, those relating to Cardiac Science Corporation's expectations regarding cost savings or improved research and development capabilities and the resulting impact on operating results. These are forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may vary significantly from the results expressed or implied in such statements. Factors that could cause or contribute to such varying results and other risks are more fully described in Cardiac Science Corporation's Annual Report on Form 10-K for the year ended December 31, 2007 and Quarterly Report on Form 10-Q for the quarter ended September 30, 2008. Cardiac Science Corporation undertakes no duty or obligation to update the information provided herein.

     For more information,
     Company Contact:
     Mike Matysik
     Cardiac Science Corporation
     Senior Vice President and CFO
     425.402.2009

     Investor Contact:
     Doug Sherk
     Jenifer Kirtland
     EVC Group Inc.
     415.896.6820

     Media Contact:
     Christopher Gale
     EVC Group Inc.
     646.201.5431
     203.570.4681
     cgale@evcgroup.com

CSCX-G


'/>"/>
SOURCE Cardiac Science
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The Sudden Cardiac Arrest Association Shoots Straight for the Heart
2. Experts Urge Limits on Use of Cardiac CT Scans
3. Proton pump inhibitors increase risk of heart attacks for patients on common cardiac drug
4. Easing regulations does not mean lower quality of cardiac care
5. New stretchable electrodes created to study stresses on cardiac cells
6. 2008 a Year of Growth and Unprecedented Service for The Larry King Cardiac Foundation
7. Cholesterol Levels May Not Measure Cardiac Risk
8. Newer Antipsychotics Pose Cardiac Risk: Study
9. Most heart attack patients cholesterol levels did not indicate cardiac risk
10. Penn study: Chances of surviving cardiac arrest depend on where patients are treated
11. Conference on cell therapy includes new session on stem cells for non-cardiac organ injury
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out ... free event, sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting ... children of all ages; it is a non-competitive, non-timed event, which is all about ...
(Date:10/13/2017)... , ... October 13, 2017 , ... “The Journey: From ... every danger possible to save lost souls in the Philippines. “The Journey: From the ... is a dedicated teacher of the Bible. She has taught all ages and currently ...
(Date:10/12/2017)... Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... centers in the U.S., announced today its plans to open a flagship location in ... will occupy the former Rooms To Go store next to Office Depot in the ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... AccentCare, a leader in post-acute health care, have expanded their existing home health ... Home Health. , AccentCare has been operating a joint venture home health company ...
(Date:10/12/2017)... ... October 12, 2017 , ... Leading pediatric oncology experts at Children’s National ... 49th Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. ... for Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., ...
Breaking Medicine News(10 mins):
(Date:9/27/2017)... Israel and NEW YORK , Sept. 27, ... with mobile health and big data solutions, today announced that its MyDario ... Please check your local TV listings for when The Dr. Oz Show ... ... season this month. ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/22/2017)... Sept. 22, 2017  As the latest Obamacare repeal ... Bill Cassidy (R-LA) and Lindsey Graham ... the medical device industry is in an odd place. ... the 2.3% excise tax on medical device sales passed ... want covered patients, increased visits and hospital customers with ...
Breaking Medicine Technology: